Invalid Symbol

Stock Research for ATBIF

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


ATBIF Stock Chart & Research Data

The ATBIF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATBIF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ATBIF Due diligence Resources & Stock Charts

The ATBIF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATBIF Detailed Price Forecast - CNN Money CNN View ATBIF Detailed Summary - Google Finance
Yahoo View ATBIF Detailed Summary - Yahoo! Finance Zacks View ATBIF Stock Research & Analysis -

Stock Analysis

TradeIdeas View ATBIF Trends & Analysis - Trade-Ideas Barrons View ATBIF Major Holders - Barrons
NASDAQ View ATBIF Call Transcripts - NASDAQ Seeking View ATBIF Breaking News & Analysis - Seeking Alpha
Spotlight View ATBIF Annual Report - OTC Report View ATBIF OTC Short Report -
TradeKing View ATBIF Fundamentals - TradeKing Charts View ATBIF SEC Filings - Bar Chart
WSJ View Historical Prices for ATBIF - The WSJ Morningstar View Performance/Total Return for ATBIF - Morningstar
MarketWatch View the Analyst Estimates for ATBIF - MarketWatch CNBC View the Earnings History for ATBIF - CNBC
StockMarketWatch View the ATBIF Earnings - StockMarketWatch MacroAxis View ATBIF Buy or Sell Recommendations - MacroAxis
Bullish View the ATBIF Bullish Patterns - American Bulls Short Pains View ATBIF Short Pain Metrics -

Social Media Mentions

StockTwits View ATBIF Stock Mentions - StockTwits PennyStocks View ATBIF Stock Mentions - PennyStockTweets
Twitter View ATBIF Stock Mentions - Twitter Invest Hub View ATBIF Investment Forum News - Investor Hub
Yahoo View ATBIF Stock Mentions - Yahoo! Message Board Seeking Alpha View ATBIF Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ATBIF - Insider Cow View Insider Transactions for ATBIF - Insider Cow
CNBC View ATBIF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATBIF - OTC Markets
Yahoo View Insider Transactions for ATBIF - Yahoo! Finance NASDAQ View Institutional Holdings for ATBIF - NASDAQ

Stock Charts

FinViz View ATBIF Stock Insight & Charts - StockCharts View ATBIF Investment Charts -
BarChart View ATBIF Stock Overview & Charts - BarChart Trading View View ATBIF User Generated Charts - Trading View

Latest Financial News for ATBIF

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Nestlé to buy vitamin maker Atrium Innovations for $2.3bn
Financial Times - Dec 5, 2017
Nestlé, the world's biggest food group, is spending $2.3bn buying Atrium Innovations, a Canadian nutritional products company, from private equity group Permira as it seeks to pep up its portfolio of consumer healthcare businesses.

Nestlé to Buy Atrium Innovations for $2.3 Billion
Wall Street Journal - Dec 5, 2017
LONDON—Nestlé SA agreed to buy Atrium Innovations Inc., a Canadian vitamin maker, for $2.3 billion, including the assumption of debt—expanding its range of consumer-health offerings as sales slow for packaged-food staples such as TV dinners and ...

Moody's reviews Atrium Innovation's ratings for upgrade on acquisition ... (press release) - Dec 6, 2017
The review will focus on the likelihood that the acquisition will close and Nestle's legal support for Atrium's debt, if any.

Atrium Innovations sold to European private equity firm for $750-million
The Globe and Mail - Nov 29, 2013
Quebec-based natural health products company Atrium Innovations Inc. is being sold for about $750-million to European private equity firm Permira.
Atrium Innovations Inc. to be acquired by the Permira funds and a group of ... - Canada NewsWire (press release)

Enter a stock symbol to view the stock details.